You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Spleen volume

Showing 1 - 25 of 7,118
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Relevance of Sarcopenia in Advanced Liver Disease

Recruiting
  • Liver Cirrhosis
  • +3 more
    • Linköping, Sweden
      Department of gastroenterology and hepatology
    Aug 12, 2022

    Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)

    Not yet recruiting
    • Metastatic Pancreatic Cancer
    • nanoliposomal irinotecan
    • spleen irradiation
    • (no location specified)
    May 8, 2022

    Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be

    Recruiting
    • Ductal Adenocarcinoma of the Pancreas
    • Whipple over the splenic artery
    • Total pancreatectomy
    • Taipei, Taiwan
      National Taiwan University Hospital
    Nov 1, 2023

    Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

    Not yet recruiting
    • Myelofibrosis
    • TQ05105 Tablets
    • TQB3617 Capsules
    • Guangzhou, Guangdong, China
    • +19 more
    Nov 7, 2023

    Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

    Not yet recruiting
    • Myelofibrosis (PMF)
    • +2 more
    • New York, New York
      Ruttenberg Treatment Center
    Apr 18, 2023

    Myelofibrosis (MF) Trial in Worldwide (Navitoclax, Ruxolitinib, Best Available Therapy (BAT))

    Recruiting
    • Myelofibrosis (MF)
    • Chandler, Arizona
    • +207 more
    Jul 26, 2022

    Myelofibrosis Trial in Worldwide (PIM447, Ruxolitinib, LEE011)

    Completed
    • Myelofibrosis
    • VIC, Melbourne, Australia
    • +8 more
    Feb 7, 2022

    Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

    Recruiting
    • Myelofibrosis
    • Jaktinib Hydrochloride Tablets
    • Hangzhou, Zhejiang, China
      The First Affiliated Hospital of Medical School of Zhejiang Univ
    Nov 28, 2022

    Primary Myelofibrosis Trial in Japan (Fedratinib)

    Recruiting
    • Primary Myelofibrosis
    • Suwa, Nagano, Japan
    • +25 more
    Jan 18, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

    Recruiting
    • Primary Myelofibrosis
    • +2 more
    • Worcester, Massachusetts
    • +16 more
    Oct 31, 2022

    Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Saint Louis, Missouri
      Washington University School of Medicine
    Oct 26, 2022

    Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

    Completed
    • Thalassemia, Beta
    • Hydroxyurea and Thalidomide
    • Karachi, Sindh, Pakistan
      Children's Hospital Karachi
    Nov 23, 2023

    Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

    Recruiting
    • Primary Myelofibrosis
    • +4 more
    • New York, New York
      Ruttenberg Treatment Center
    Jul 18, 2022

    Myeloproliferative Tumors Trial in Worldwide (INCA033989, Ruxolitinib)

    Recruiting
    • Myeloproliferative Neoplasms
    • Herston, Queensland, Australia
    • +22 more
    Jun 30, 2023

    Gaucher Disease, Type 1, Gaucher Disease, Type 3 Trial in Beijing (Low-dose CAN103, High-dose CAN103)

    Recruiting
    • Gaucher Disease, Type 1
    • Gaucher Disease, Type 3
    • Low-dose CAN103
    • High-dose CAN103
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jul 25, 2022

    Gynecologic Cancer, Cervical Cancer, Endometrial Cancer Trial in Taoyuan City (Hyperpolarized 13C-Pyruvate injection)

    Not yet recruiting
    • Gynecologic Cancer
    • +3 more
    • Hyperpolarized 13C-Pyruvate injection
    • Taoyuan City, Guishan District, Taiwan
      Chang Gung Memorial Hospital
    Apr 5, 2023

    Myelofibrosis Trial in Worldwide (Selinexor, Physician's Choice Treatment)

    Recruiting
    • Myelofibrosis
    • Los Angeles, California
    • +41 more
    Jan 30, 2023

    Brain Injuries, Traumatic, Brain Injuries, Acute, TBI (Traumatic Brain Injury) Trial in Houston (Placebo Infusion, Autologous

    Enrolling by invitation
    • Brain Injuries, Traumatic
    • +2 more
    • Placebo Infusion
    • Autologous BMMNC Infusion
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Aug 1, 2022

    Myeloproliferative Tumor, Chronic Neutrophilic Leukemia, MDS Trial in Tampa (Fedratinib Pill)

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Fedratinib Pill
    • Tampa, Florida
      Moffitt Cancer Center
    Jun 15, 2022

    Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)

    Enrolling by invitation
    • Thrombocythemia, Essential
    • Primary Myelofibrosis
    • Miami, Florida
    • +18 more
    Jan 30, 2023

    Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

    Active, not recruiting
    • Myelofibrosis
    • +2 more
    • New Orleans, Louisiana
    • +20 more
    Aug 25, 2022

    Myelofibrosis Trial in Jinan (Ruxolitinib)

    Recruiting
    • Myelofibrosis
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    Jul 3, 2022

    Velaglucerase Alfa Given as Standard Patient Care in Young

    Recruiting
    • Gaucher Disease
    • Standard of Care
    • Fairfax, Virginia
      Lysosomal & Rare Disorders Research & Treatment Center
    Jan 5, 2023

    Ruxolitinib in Patients With Myelofibrosis

    Completed
    • Myelofibrosis
    • (no location specified)
    Jun 5, 2022